VYNE Therapeutics Inc. Common Stock
XNAS:VYNE
0.55
$0.80 - 28.00
$0.55 - 10,000.00
$0.55
$0.57
$0.56
$0.57
2.94
0.28
855174
535673.1
30762125.86
Chart
TendieTensor AI Analysis
Company
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.
Fundamentals
13
-0.720000
0.560539
100
BBG00H5W8GM8
BBG00H5W8GN7
25.47M
25.47M
Technicals
Short Interest
—
—
—
Higher = harder to cover
—
Prev: —
—
—
5D avg: —
—
Discussion
Login to participate in discussions.
Recent News
Related Stocks
Based on the portfolios of people who own VYNE. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.